A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
Our previous study indicated that intravenous vitamin C (IVC) treatment concurrent with modulated electrohyperthermia (mEHT) was safe and improved the quality of life (QoL) of non-small-cell lung cancer (NSCLC) patients. The aim of this trial was to further verify the efficacy of the above combinati...
Main Authors: | Junwen Ou, Xinyu Zhu, Pengfei Chen, Yanping Du, Yimin Lu, Xiufan Peng, Shuang Bao, Junhua Wang, Xinting Zhang, Tao Zhang, Clifford L.K. Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Journal of Advanced Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090123220300539 |
Similar Items
-
Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia
by: Mau-Shin Chi, et al.
Published: (2020-03-01) -
Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma
by: SS Bessmeltsev, et al.
Published: (2019-12-01) -
Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects
by: Balázs Besztercei, et al.
Published: (2019-08-01) -
A Bayesian Network Meta-Analysis Comparing the Efficacies of Eleven Novel Therapies with the Common Salvage Regimen for Relapsed or Refractory Acute Myeloid Leukemia
by: Juan Huang, et al.
Published: (2018-09-01) -
Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
by: Stefaan W. Van Gool, et al.
Published: (2021-12-01)